NEU 2.49% $14.40 neuren pharmaceuticals limited

Ann: Comment on research report, page-218

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,139 Posts.
    lightbulb Created with Sketch. 122
    SUMMARY Inventors have identified a new problem in the industry, namely that current methods of producing compositions containing trofinetide are difficult to adapt to commercial quantities. To address this problem, we have identified new compositions and production methods in which the compound or salt or stereoisomer or hydrate is produced using silylation technology. The use of this new strategy involves the production of new compositions and substantially larger quantities of trofinetide and results in compositions, kits and products containing trofinetide that are commercially beneficial.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.